Screening automation bottlenecks remain a critical constraint in high-throughput screening (HTS) environments, directly impacting assay throughput, data quality, and overall drug discovery timelines.

Molecular Devices developed an end-to-end, automated workflow, beginning with assay-ready colorectal cancer organoids, comprising establishment in culture, maintenance, and screening. Automation ...

Rising Demand for High-Throughput Screening, AI-Powered Laboratories, and Workforce Efficiency Continues to Drive Market ...

Accelerating Drug Discovery with AI and Next-Generation Automation The pharmaceutical industry is currently witnessi ...

In this interview, AZoLife Sciences speaks with Boyd Butler, a microscopy and high-content screening expert at Molecular ...

High-throughput screening (HTS) is a cornerstone of modern drug discovery, enabling the evaluation of thousands to millions of potential drug compounds. Advances in automation and miniaturization have ...

DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb Genomics, a pioneer in comprehensive single-cell multiomic research solutions, optimized a high-throughput workflow of BioSkryb’s ResolveDNA ® Single-Cell Whole ...

Loop-mediated isothermal amplification (LAMP), a DNA amplification technique valued for its speed, specificity, sensitivity, and simplicity, is increasingly employed in disease diagnostics and ...

To enhance productivity in research laboratories conducting genomic studies, automation techniques along with rapid workflows are encouraged. Here, we discuss gene expression analysis by ...